Signaturefd, LLC Cyma Bay Therapeutics, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$12.63 - $24.47 $2,071 - $4,013	164 Added 81.59%	365 $8,000
Q3 2023 Nov 03, 2023	BUY	$10.86 - $17.62 $2,182 - $3,541	201 New	201 $2,000
Q4 2022 Jan 27, 2023	BUY	$3.22 - $6.27 $373 - $727	116 New	116 $0
Q4 2021 Jan 25, 2022	SELL	$3.23 - $4.6 $24,871 - $35,420	-7,700 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$3.47 - $4.42 $586 - $746	-169 Reduced 2.15%	7,700 $28,000
Q2 2021 Jul 26, 2021	SELL	$3.94 - $4.92 $2,545 - $3,178	-646 Reduced 7.59%	7,869 $34,000
Q1 2021 Apr 30, 2021	BUY	$4.23 - $6.55 $36,018 - $55,773	8,515 New	8,515 $39,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.